A recent study from researchers at Washington State University has shown success in keeping semen in its gel form to block sperm movement and possibly prevent pregnancy. The methods used in this study may eventually materialize into a non-hormonal female contraception method that could be available for over-the-counter purchase. Past research on mice found that the use of a non-specific protease inhibitor called AEBSF prevented the degradation of the protein of Semenogelin 1. Semenogelin 1 (SEMG1) is a protein that traps semen and prevents movement; therefore, its degradation is necessary for sperm liquefaction, where semen is transformed from a gel-like consistency to liquid. By inhibiting the degradation of SEMG1, the researchers were able to prevent the female mice from becoming pregnant. To determine the efficacy of these inhibitors in humans for contraception, the study tested the effects of AEBSF on SEMG1 degradation, which prevented degradation and reduced sperm motility. They next tested the results of a neutralizing antibody that directly inhibited...

The annual International Conference on Family Planning (ICFP) took place November 14-17 in Pattaya City, Thailand. This conference featured various stakeholders, organizations, government officials, and care providers who met to discuss the current global trends in family planning and reproductive health and discuss creative solutions to address some of the major issues. The conference designates itself as “a platform, a movement, and a community” where commitments, advancements, and achievements can be shared and made. The conference offered a wide array of sessions and speaker events, discussing relevant issues, such as “From idea to implementation: Delivering on the promise of contraceptive technology innovation,” “FP2030: An all-Inclusive Look: Tailored FP Services to Meet the Needs of LGBTI groups,” “Progress and Rollbacks: US restrictions on abortion rights in a global context,” and many more. Many organizations and researchers were able to present their current research on new family planning technologies. The 2022 conference theme explored Universal Health Coverage and how it relates to...

In October 2022, the Regional Gender Task Force (RGTF) published a report titled “Making the Invisible Visible: An evidence-based analysis of gender in the regional response to the war in Ukraine” describing the adverse impacts of the ongoing conflict on all genders and marginalized groups. The section “Sexual and Reproductive Health and Rights” is dedicated to discussing SRHR issues that have arisen in the war, as well as solutions through the humanitarian response. While few restrictions are present in Ukraine for Sexual and Reproductive Health (SRH) services, many surrounding countries have strict policies that limit abortions and make contraceptive access difficult. Legal, language, and financial barriers have restricted Ukrainian refugees from seeking high-quality SRH, increasing the risk of adverse SRH outcomes. The conflict has also increased the difficulty in accessing SRH services in Ukraine or neighboring countries, due to the attacks on health-related infrastructure and disruption of health and SRH organizations. According to the report, disruptions in health care services and...